Metabolic and bariatric surgery, particularly Roux-en-Y gastric bypass, may be beneficial for improving body weight, waist circumference, type 2 diabetes status and long-term blood sugar levels in adults with obesity and type 2 diabetes compared to lifestyle and medication therapies alone, according to a network meta-analysis of 18 clinical studies involving 15,282 participants updated in June 2024.
Obesity and type 2 diabetes frequently co-exist, amplifying risks of premature death and health problems such as cardiovascular disease. When conventional lifestyle interventions—such as nutrition, exercise, and behavioural programmes—combined with medicines fail to work well, metabolic and bariatric surgery may be considered as an additional treatment option.
In Plain English: The Clinical Takeaway
- Roux-en-Y Gastric Bypass: This procedure may improve body weight and likely reduce waist circumference compared with lifestyle and medication treatment. It may also improve blood sugar levels and reduce type 2 diabetes complications, though for complications, results are very uncertain.
- Uncertainty Surrounding Procedures: While one-anastomosis gastric bypass, gastric sleeve, and gastric band show potential benefits, researchers are very uncertain about the results for one-anastomosis gastric bypass, and for all these procedures regarding diabetes status and blood sugar.
- Safety and Mortality Data: It is unclear whether the types of surgery have an effect on serious unwanted health effects or death from any cause.
Comparative Efficacy of Metabolic Procedures at Five Years
The comprehensive network meta-analysis evaluated 18 studies comprising 15,282 individuals. Among these, 13 studies utilized randomized controlled designs covering 911 participants, while five observational studies contributed data from 14,371 patients. Researchers assessed multiple surgical interventions, including Roux-en-Y gastric bypass, one-anastomosis gastric bypass, sleeve gastrectomy, gastric banding, and gastric plication.
Data indicates that Roux-en-Y gastric bypass may improve body weight and likely reduce waist circumference while improving blood sugar levels and reducing type 2 diabetes complications relative to non-surgical treatments. Procedures like one-anastomosis gastric bypass and gastric sleeve also show potential for weight and waist circumference improvement, and one-anastomosis gastric bypass and gastric sleeve may improve blood sugar levels, but the evidence is very uncertain. Furthermore, while health-related quality of life scores tended to increase following Roux-en-Y gastric bypass and sleeve gastrectomy compared to non-surgical treatments, the overall certainty of this evidence remains very low.
| Intervention | Effect on Body Weight & Waist Circumference | Effect on Blood Sugar & Diabetes Status | Certainty of Evidence |
|---|---|---|---|
| Roux-en-Y Gastric Bypass | Improves weight and likely reduces waist circumference | Improves blood sugar and may reduce complications | Low to very low |
| One-Anastomosis Gastric Bypass | May improve weight and waist circumference | May improve diabetes status and blood sugar | Very low |
| Gastric Sleeve | May improve weight and waist circumference | May improve diabetes status and blood sugar | Very low |
| Gastric Band | Not explicitly stated | May improve diabetes status | Very low |
Methodological Limitations
Translating these surgical findings into clinical practice requires careful appraisal of study limitations. The certainty of evidence across outcomes was often low to very low. This rating stemmed primarily from small sample sizes in randomized trials and a scarcity of documented events concerning serious unwanted health effects, all-cause mortality, and type 2 diabetes complications. Moreover, for several surgical procedures, there were not enough studies to be certain about the outcomes.
When to Consult a Doctor
Metabolic and bariatric surgery may be considered as an additional treatment option when lifestyle interventions and medicines do not work well.
References
- PubMed Central: Network Meta-Analysis of Bariatric Surgery for Obesity and Type 2 Diabetes
- Cochrane Database of Systematic Reviews: Long-term benefits and risks of metabolic and bariatric surgery
Disclaimer: This article does not constitute formal medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding individual surgical candidacy and metabolic management.
